(Q48505199)

English

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

scientific article published on 4 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Masaaki Mori

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Syuji Takei

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Tomoyuki Imagawa

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Hiroyuki Imanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Yasuhito Nerome

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Rumiko Higuchi

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Yoshifumi Kawano

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Shumpei Yokota

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Noriko Sugiyama

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Hirotoshi Yuasa

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Tracey Fletcher

11

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Joseph S Wajdula

12

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

publication date

4 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Modern Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

22

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

720-726

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0578-5

21 January 2018

Identifiers

10.3109/S10165-011-0578-5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22212889

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48505199&oldid=2200614362"